Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. TWO /
  3. 6547.TWO

Medigen Vaccine Biologics (6547 TWO) stock market data APIs

NT$48 -0.5(-1%) as of July 26, 2024
Price chart is built with Anychart

Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. The company is developing enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection; influenza vaccine, which has completed Phase III clinical trial to treat influenza; dengue vaccine, which has completed Phase II clinical trial for the treatment of dengue fever; respiratory cell fusion virus (RSV) antibody, which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19- severe special infectious pneumonia. Medigen Vaccine Biologics Corporation was founded in 2012 and is based in Taipei, Taiwan. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp.

Medigen Vaccine Biologics Financial Data Overview

48.5
48
-
48.6
47.9
47.85-81.5
15 937 M
329 M
448 M
-1.77
0.794
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '6547',
Type: 'Common Stock',
Name: 'Medigen Vaccine Biologics',
Exchange: 'TWO',
CurrencyCode: 'TWD',
CurrencyName: 'New Taiwan Dollar',
CurrencySymbol: 'NT$',
CountryName: 'Taiwan',
CountryISO: 'TW',
OpenFigi: NULL,
ISIN: 'TW0006547003',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Medigen Vaccine Biologics Fundamental Data is available in our Financial Data APIs

  • Net Revenue 448 M
  • EBITDA -979 475 968
  • Earnings Per Share -3.1
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Medigen Vaccine Biologics Earnings via APIs

  • Latest Release 2024-03-08
  • EPS/Forecast -0.49

Get Medigen Vaccine Biologics End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Medigen Vaccine Biologics latest news via APIs

Dynavax (DVAX) Gains as Medigen Rolls Out COVID-19 Vaccine

Shares of Dynavax Technologies Corporation DVAX jumped 14.4% after its Taiwan-based partner Medigen Vaccine Biologics Corporation announced the rollout of its COVID-19 vaccine — MVC-COV1901 — in t...
  • ADJUVANTED
  • DYNAVAX TECHNOLOGIES CORPORATION
  • HEPATITIS B VACCINE
  • MEDIGEN
  • MEDIGEN VACCINE BIOLOGICS CORPORATION
  • REPLIGEN CORPORATION
  • SUBUNIT VACCINE
  • VACCINE CANDIDATE
  • ZACKS INVESTMENT RESEARCH

Powered By Dynavax Adjuvant, Medigen COVID-19 Vaccine Launched In Taiwan

Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation (NASDAQ: DVAX) announced the rollout of their COVID-19 vaccine, MVC-COV1901, in Taiwan. Approximately 600,000 people are anti...
  • DYNAVAX TECHNOLOGIES CORPORATION
  • MEDIGEN
  • MEDIGEN VACCINE BIOLOGICS CORPORATION
  • SUBUNIT VACCINE
  • TAIWAN
  • TAIWAN EMERGENCY USE AUTHORIZATION
  • VACCINE EFFECTIVENESS
Do you have any questions?
support@eodhistoricaldata.com